Detalhe da pesquisa
1.
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.
Oncologist
; 28(3): 230-238, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811382
2.
The Role of Immunotherapy in the Treatment of Anal Cancer and Future Strategies.
Curr Treat Options Oncol
; 23(8): 1073-1085, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666353
3.
Advancements in combining targeted therapy and immunotherapy for colorectal cancer.
Trends Cancer
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38821852
4.
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
Cancer Res Commun
; 3(12): 2510-2517, 2023 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085001
5.
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
Cancer Immunol Res
; 11(7): 925-945, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172100
6.
Anal Cancer: Emerging Standards in a Rare Disease.
J Clin Oncol
; 40(24): 2774-2788, 2022 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35649196
7.
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer.
J Natl Cancer Inst
; 113(2): 208-211, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294214
8.
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma.
Oncotarget
; 8(24): 39268-39279, 2017 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424412